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Abstract
Serine proteinase inhibitors of the serpin family are well known as negative regulators of hemostasis, thrombolysis and
innate immune responses. Additionally, non-inhibitory serpins serve functions as chaperones, hormone transporters, or anti-
angiogenic factors. In the African malaria mosquito, Anopheles gambiae s.s., at least three serpins (SRPNs) are implicated in
the innate immune response against malaria parasites. Based on reverse genetic and cell biological analyses, AgSRPN6 limits
parasite numbers and transmission and has been postulated to control melanization and complement function in
mosquitoes. This study aimed to characterize AgSRPN6 biophysically and determine its biochemical mode of action. The
structure model of AgSRPN6, as predicted by I-Tasser showed the protein in the native serpin fold, with three central b-
sheets, nine surrounding a-helices, and a protruding reactive center loop. This structure is in agreement with biophysical
and functional data obtained from recombinant (r) AgSRPN6, produced in Escherichia coli. The physical properties of
purified rAgSRPN6 were investigated by means of analytical ultracentrifugation, circular dichroism, and differential scanning
calorimetry tools. The recombinant protein exists predominantly as a monomer in solution, is composed of a mixture of a-
helices and b-sheets, and has a mid-point unfolding temperature of 56uC. Recombinant AgSRPN6 strongly inhibited porcine
pancreatic kallikrein and to a lesser extent bovine pancreatic trypsin in vitro. Furthermore, rAgSRPN6 formed inhibitory, SDS-
stable, higher molecular weight complexes with prophenoloxidase-activating proteinase (PAP)1, PAP3, and Hemolymph
protein (HP)6, which are required for melanization in the lepidopteran model organism, Manduca sexta. Taken together, our
results strongly suggest that AgSRPN6 takes on a native serpin fold and is an inhibitor of trypsin-like serine proteinases.
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Introduction
The concept that mosquito immunity could be an important
determinant of the infectivity of malaria parasites for different
mosquito species was put forward 85 years ago [1]. Even in
permissive parasite-vector species combinations, the parasite
population undergoes substantial stage-specific losses during its
development in the mosquito [2,3]. Manipulation of the mosquito
immune system has been acknowledged as a mechanism to kill
malaria parasites within its vector [4–9], and the identification of
effector mechanisms and molecules that limit parasite develop-
ment within its mosquito vector remains a research priority.
Proteolytic cascades take a central role in many immune
reactions as they amplify the invasion signal and activate various
lines of attack against the pathogen. Serine proteinase inhibitors of
the serpin family inhibit many of these reactions in arthropods.
This includes the hemolymph coagulation cascade in horseshoe
crabs [10], proteolytic activation of spa¨tzle and thus the Toll
pathway [11–15], and proteolytic activation of pro-phenoloxidase
(proPO) and as a consequence melanization [16–21]. Mosquito
serpins (SRPNs) have been shown to control melanization [22–25]
and host hemostasis during bloodmeal [26,27]. Additionally, they
act as acute response molecules as An. gambiae (Ag)SRPN6 and
AgSRPN10 are significantly and transiently upregulated during
malaria parasite invasion of the midgut [28,29] and, in case of
AgSRPN6, also the salivary glands [30].
Serpins are the largest family of serine proteinase inhibitors and
are found in all higher eukaryotes as well as bacteria and viruses
(most recently reviewed by [31]). Serpins are metastable proteins
that function as structurally conserved suicide substrates [32,33].
Most serpins inhibit serine proteinases of the chymotrypsin type,
but some are cross-class inhibitors that can also target cysteine
proteinases [34,35]. Additionally, some serpins no longer function
as proteinase inhibitors but have adopted other roles including
hormone transport [36], blood pressure regulation [37], and
storage [38]. They can be found intra- as well as extracellularly,
and are usually 350–400 amino acid residues long. Although
amino acid sequence similarity varies from 17 to 95% across all
serpins, key conserved residues facilitate the folding of inhibitory
serpins into a metastable conformation typically comprising three
b-sheets, eight to nine a-helices, and the solvent-exposed reactive
center loop (RCL). Their RCL binds to the active site of the
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specific target proteinase similar to the binding of a substrate.
Upon cleavage of the serpin at its so-called scissile bond
(designated P1-P19), the serpin undergoes a substantial conforma-
tional ‘‘stressed-to-relaxed’’ transition, which covalently traps the
target proteinase [33,39]. Crystal structures of serpins provide
additional information into their mechanism of inhibition. So far,
more than 80 serpin crystal structures in five distinct conforma-
tional states have been solved [39]. To date, protein structures of
only a few insect serpins are available. The crystal structure of
AgSRPN2 was solved recently in its native conformation [40], and
constitutes the first serpin fold described from a dipteran insect. A
striking difference between AgSRPN2 and most other native
serpins lies in the conformation of the N-terminal hinge region of
the RCL, which has partially inserted between two strands of b-
sheet A, suggesting an activation mechanism that parallels heparin
action on antithrombin III (ATIII) [41–43].
A small number of SRPNs have been analyzed for their
potential involvement in malaria parasite transmission. AgSRPN6,
which is a biomarker for malaria parasite invasion, limits the
number of rodent malaria parasites that progress through the
midgut and salivary gland epithelium [29,30]. Depletion of
AsSRPN6 by RNAi in susceptible An. stephensi leads to a significant
increase in the number of developing P. berghei oocysts, whereas
AgSRPN6 depletion in susceptible An. gambiae has no effect on the
number of developing parasites but delays the progression of
parasite lysis by the complement system and may additionally limit
melanization. These observed phenotypic differences are possibly
due to changed roles of the respective target serine proteinases in
the two mosquito species as both SRPN6 proteins contain identical
RCLs. Additionally, knock-down of AgSRPN6 significantly in-
creases the number of sporozoites reaching the salivary glands. Its
endogenous target proteinase(s) await identification, and any
western blots performed so far have not revealed any higher
molecular bands indicative for serpin-proteinase complexes. It is
tempting to speculate that SRPN6 may directly interfere with the
function of a parasite proteinase required for epithelial invasion
and/or traversal. At least the SRPN6-depletion phenotype would
be consistent with such a scenario. However, it remains unclear
whether SRPN6 functions as an inhibitory or non-inhibitory
serpin.
In the present study, we produced recombinant (r)AgSRPN6 in
Escherichia coli, characterized its biochemical and physical proper-
ties and tested its inhibitory activity using commercial proteinases.
We demonstrate that rAgSRPN6 takes on a native conformation
and can function as an inhibitor of trypsin-like serine proteinases.
Materials and Methods
Protein structure modeling
Structure predictions were performed using the I-Tasser server
without additional constraints or templates [44,45]. The following
amino acid sequence (AGAP009212-PA, REF Seq: XP_319990)
was submitted online in August 2010: QWNRYYTQAPQARYTPMVR-
TAQRVALRHSFETDGTPAPSTVRPRPPAPPTNAPSQLPALTPDNDAKIS-
QLVVDFMMRISRTLPQQQSRTELFSPLSIITVANLLFLGSGGSTHEEFG-
KVLTPSSMNWKRMHQRYGNVLANLMSPEPIDSRRDQWRRQTCPRDDDYE-
DGEGGPAPKSQVIRVANGIFYQKDLPMRQQYVMLARSLYGALIQPIDPQ-
ASAASTALINRWVSDVTAGKIRNMLEGPLSPSSSVVIANALYFKAKWKT-
QFEPLVTRDAPFFPDGLDGPSYRVKMMSMSGCLPFYRVRDSLDTTIVGL-
PYRDDTSTMYLIQPANSSRTAIRRLQATLTGKMLDSWISQMKLQSTMVR-
LPKMHLRNSVDLLQSFQKLGFNSILSPAKSDLSNMIDSSSSAGPKPYVN-
QILHKLDLTIDEEGTEGAAATSALVDRIGSQRQFNGNAPFLIYLRHDAT-
GLPLFYGPIFDPR
Expression and purification of recombinant proteins
To express full-length rAgSRPN6, the entire AgSRPN6 coding
region, excluding the signal peptide, was amplified by PCR using
SRPN6.3/pGEMT-easy plasmid [29] as template with the
following primer pair: S6F: 59-TACCATGGGCCATCATCAT-
CATCATCACGGCCAGTGGAATCGGTACTACA-39 (NcoI
restriction site underlined, start codon italicized, and codons for
six histidine residues double-underlined); S6R: 59-CGAAGCTTT-
TAGCGCGGATCGAATATCGGCCCG-39 (HindIII restriction
site underlined). The PCR product was digested with NcoI and
HindIII, and inserted into the same restriction sites in the
expression vector pET-28a (Novagen EMD, Rockland, MS,
USA). N-terminal His-tagged rSRPN6 protein was expressed
and purified as reported previously [24].
For the generation of antibodies against AgSRPN6 a cDNA
fragment encoding the C-terminal 201 amino acid residues of the
protein was amplified by PCR using SRPN6.3/pGEMT-easy
plasmid [29] as template with the following primers: S6AgF: 59-
TACCATGGGCCATCATCATCATCATCACGGCGATG-
CACCCTTCTTCCCGGA-39 (NcoI restriction site underlined,
start codon italicized, codons for six histidine residues double-
underlined); and primer S6R. The PCR product was digested and
subcloned into vector pET28a (Novagen) as described above.
Recombinant N-terminally His-tagged SRPN6Ag was expressed
in a one liter culture of E. coli strain BL21 with 0.1 mM of
isopropyl b-D-thiogalactoside for 5 h at 20uC, 250 rpm.
SRPN6Ag was expressed in an insoluble form and therefore was
purified under denaturing conditions by nickel-nitrilotriacetic acid
agarose affinity chromatography (Qiagen, Valencia, CA, USA)
[46]. An aliquot of the purified recombinant SRPN6Ag (1.5 mg)
was further resolved by preparative SDS-PAGE and used for
polyclonal rabbit antiserum production (Cocalico Biologicals,
Reamstown, PA, USA).
Recombinant M. sexta proHP6 (proHP6Xa), in which the
cleavage activation site LDLH92 was replaced with IEGR92 to
permit its activation by bovine Factor Xa, was prepared and
activated by Factor Xa as described previously [47]. Recombinant
active M. sexta PAP1 and PAP3 were kindly provided by Dr.
Haobo Jiang (Oklahoma State University) and Dr. Maureen
Gorman (Kansas State University), respectively.
Proteinase inhibition assays
To measure the inhibitory activities of AgSRPN6, the
recombinant protein was incubated with various commercial
proteinases at different molar ratios in 0.1 M Tris, pH 8.0. 3 mg of
BSA was included in each reaction. After incubation at room
temperature for 10 min, 200 ml of appropriate chromogenic
substrate solution (100 mM in 0.1 M Tris-HCl, 0.1 M NaCl,
5 mM CaCl2, pH 8.0) was added, and residual enzyme activity
was immediately measured at A405 in a PowerWave XS
microplate reader (Bio-Tek, Winooski, VT, USA). One unit of
amidase activity was defined as DA405 = 0.001/min. The
following proteinases and their artificial substrate were used:
human leukocyticcathepsin G (200 ng) and N-succinyl-Ala-Ala-
Pro-Phe-p-nitroanilide; bovine pancreatic a-chymotrypsin
(120 ng) andN-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide; porcine
pancreatic elastase (2 mg) and N-succinyl-Ala-Ala-Pro-Leu-p-
nitroanilide; porcine pancreatic kallikrein (700 ng) and D-Phe-L-
Pro-L-Arg-p-nitroanilide; human serum plasmin (200 ng) and D-
Phe-L-Pro-L-Arg-p-nitroanilide; proteinase K from the fungus
Tritirchium album (40 ng) and N-succinyl-Ala-Ala-Pro-Phe-p-nitroa-
nilide; subtilisin Carlsberg from Bacillus licheniformis (50 ng) and N-
benzoyl-Phe-Val-Arg-p-nitroanilide; human serum thrombin
(30 ng) andN-benzoyl-Phe-Val-Arg-p-nitroanilide; bovine pancre-
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atic trypsin (5 ng) and N-acetyl-Ile-Glu-Ala-Arg-p-nitroanilide
(Biochemistry Core Facility, Kansas State University). All
proteinases and substrates were purchased from Sigma-Aldrich
(St. Louis, MO, USA), with the exception of proteinase K
(Promega, Madison, WI, USA) and N-acetyl-Ile-Glu-Ala-Arg-p-
nitroanilide, which was synthesized in-house.
Sedimentation velocity
Purified intact rAgSRPN6 was dialyzed against 20 mM Tris
and 250 mM NaCl, pH 8.0 at 4uC for 24 h with one buffer
exchange to reach a concentration of 1.0 mg/ml. Same dialysis
buffer was used as a blank. Sedimentation velocity runs were
performed in an Optima XL-I analytical ultracentrifuge (Beckman
Coulter, Brea, CA, USA) at 49,000 rpm, 25uC in an An-60 Ti
rotor. Sedimentation was monitored at 280 nm using double
sector cells with a final loading of 400 ml per well. Acquired data
were analyzed using DCDT+ software version 1.16, and
sedimentation coefficients were calculated using g(s*) fitting
function in the DCDT+ software [48].
Circular dichroism
To investigate the effect of pH on the CD spectrum of
rAgSRPN6, purified protein was dialyzed as above and the pH
was adjusted to 5.0 or 11.0 by stepwise addition of either 0.1 M
HCl or 1.0 M NaOH. Samples were centrifuged at 13,000 rpm
for 5 min to remove any pellet resulting from pH change. Far-UV
CD spectra (190–260 nm) were recorded at 25uC with a Jasco J-
815 CD Spectrometer (Jasco Corporation, Tokyo, Japan). A cell of
0.2 mm path length was used in the scanning from 260 nm to
190 nm with a scan rate of 50 nm/min. Spectra were the
averaged over ten scans. All CD spectra were smoothed and
corrected by background subtraction for the spectrum obtained
with buffer alone. Data were expressed as molar ellipticity per
mean residue ([h] = degree N cm2N dmol21) with a calculated mean
residue molecular weight of 111.78, based on a molecular weight
of 53,877 Da and 482 amino acid residues.
Differential scanning calorimetry
To check the thermal stability of rAgSRPN6, purified protein
(1.0 mg/ml) was dialyzed as above, degassed, and loaded into VP-
DSC MicroCalorimeter (MicroCalTM Inc.). Temperature was
scanned at 1uC/min from 20uC to 85uC. Heat capacity, Cp (kcal/
mol/uC), was plotted after background subtraction of a blank
experiment without protein.
Formation of SDS-stable complexes between rSRPN6 and
proteinase
Active M. sexta PAP1 (15 ng) or PAP3 (20 ng) was incubated
with 200 ng of purified rAgSRPN6 (molar ratio of 1:10 for
proteinase/serpin) at room temperature for 10 min and then
treated with SDS reducing sample buffer at 95uC for 5 min. The
reaction mixtures were resolved by 10% SDS -polyacrylamide gel
electrophoresis and subjected to Western blot analysis using
1:2,000 diluted antiserum against M. sexta PAP-1 [49], PAP-3 [18]
or AgSRPN6 as primary antibodies. 15 ng of recombinant
proHP6Xa was produced and activated as described previously
[47], and mixed with purified rAgSRPN6 at a molar ratio of 1:10
(HP6/SRPN6). In control samples, proHP6Xa or factor Xa were
omitted from the mixture. After incubation at room temperature
for 10 min, the reaction mixtures were analyzed by immunoblot-
ting using antiserum against M. sexta HP6 [50] and AgSRPN6.
ProPO activation assays
To investigate the effect of rAgSRPN6 on proPO activation,
cell-free hemolymph was collected from day-2 fifth instar M. sexta
larvae as described previously [19]. 200 ng of recombinant
rAgSRPN6 (or rAgSRPN7 as negative control) was mixed with
1 ml of hemolymph for 10 min at room temperature. Subsequent-
ly, 1 ml of Micrococcus luteus (10 mg/ml in sterile water, Sigma) was
added to trigger proPO activation in the hemolymph. After
incubation for 10 min at room temperature, PO activity was
measured using dopamine as a substrate. One unit of PO activity
was defined as the amount of enzyme producing an increase in
absorbance (DA470) of 0.001 per min.
Results and Discussion
AgSRPN6 mediates mosquito innate immune response against
malaria parasites with unknown mechanisms [29,30]. To gain
further insight into AgSRPN6’s mode of action, we investigated its
structural, biophysical, and biochemical properties using model-
ing, circular dichroism, differential scanning calorimetry, and
amidase activity assays.
Protein Structure Prediction of SRPN6
Since no structure is currently available for AgSRPN6, a
predicted 3-dimensional model was computed using the I-
TASSER server [44,45], which yielded a C-score of 20.77 and
TM score of 0.62 (0.14) for the top model. The predicted structure
is similar to the native fold of other serpins consisting of three b-
sheet domains, 8 a-helices and a RCL (Figure 1). A comparison
with other structures suggested that SRPN6 overall shares highest
similarity with human antithrombin III (PDB: 1E03, chain I) with
a calculated RMSD of 1.47 A˚. Similarity to AgSRPN2, the only
mosquito serpin for which the protein structure was solved by X-
ray crystallography, is lower, with a calculated RMSD of 1.69 A˚
(PDB: 3PZF, [40]). Similarity to M. sexta Serpin 1K (PDB: 1SEK,
[51]) is comparable with an RMSD of 1.67 A˚, and likewise to T.
molitor Serpin48 (PDB: 3OZQ, [52]) with an RMSD of 1.63 A˚.
Sequence comparison between AgSRPN6 and other arthropod
serpins had previously revealed an insertion of 27 amino acids (aa
146–174) between helix D and strand 2A. This insertion is
restricted to the members of a mosquito-specific expansion cluster
including SRPN4, 5, 6, 16 and 19 [22,53]. The structure of this
insertion is predicted to form two one turn a-helices above and
perpendicular to helices D and E (Fig. 1A, maroon). An additional
feature of SRPN6 is a 41 amino acid long C-terminal extension.
This extension is predicted to form a short b-sheet, which runs
parallel to helix D (Figure 1A, pink). Several hydrogen bonds are
predicted between the insertion and N-terminal extension,
specifically between amino acid residues 19/162, 20/164, 20/
158, 21/151, and 23/148, suggesting that these two structural
features interact and stabilize each other. Additionally, the
insertion contains several aspartic acid residues that form a
negatively charged surface area which could be an important
binding site. Relatively few serpins with either insertions within the
core serpin fold, or N-terminal extensions, can be found in the
literature. An interesting example is the D. melanogaster Necrotic
serpin, which has an N-terminal extension that is cleaved on
immune-challenge. This cleavage modifies the affinity of the Nec
serpin for Elastase, and presumably it’s in vivo target proteinase
[54]. If the N-terminal extension in AgSRPN6 is cleaved in vivo is
currently unknown.
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Production of recombinant An. gambiae SRPN6
To further characterize AgSRPN6, we expressed recombinant
protein, excluding signal peptide, in E. coli (Fig. 2A). Primary trials
indicated almost all rAgSRPN6 was insoluble after expression at
37uC. Therefore, large scale production of soluble, rAgSRPN6
was expressed at a lower temperature of 20uC with low speed
shaking at150 rpm. The N-terminally His-tagged recombinant
SRPN6 was purified by Ni-NTA affinity chromatography,
followed by SP-sepharose cation exchange chromatography.
Approximately 20 mg of rAgSRPN6 could be obtained from
1.5 L of bacterial culture. SDS-PAGE analysis of recombinant
SRPN6 indicated purified SRPN6 was of high purity (Fig. 2B) with
the apparent molecular weight of 54 kDa. In addition to this
major band, another band at 53 kDa position appeared in some
fractions. N-terminal sequencing results confirmed that this band
was an N-terminally truncated form of rAgSRPN6 (SRPN6DN)
degraded after Arg40, different from predicted P1 cleavage site
Arg459 [29]. Incubation of full-length rSRPN6 with E. coli cell
lysates resulted in the appearance of this truncated band (Fig. 2B).
Therefore, appearance of truncated forms is likely due to the
cleavage by unknown E. coli proteinases and therefore an artifact
of the isolation procedure. Full-length rAgSRPN6 form was
separated from the truncated form by SP-sepharose cation
exchange chromatography, and used for all subsequent analyses.
Additionally, a C-terminal rAgSRPN6 form, SRPN6Ag,
covering the last 201 amino acid residues of full-length SRPN6
was produced. This polypeptide was insoluble, and purified under
denaturing conditions by Ni-NTA and preparative SDS-PAGE.
SRPN6Ag was used successfully to produce polyclonal antibodies
against AgSRPN6 (Fig. S1).
Biophysical and structural parameters of recombinant
SRPN6
To gain information on the structural parameters of rAgSRPN6
in solution, we performed sedimentation velocity experiments by
analytical ultracentrifugation (Fig. 3A). The sample contained a
single molecule species with the sedimentation coefficient of 3.74
Svedberg units and the molecular mass was calculated as
53.6 kDa. This is approximately equal to the molecular weight
(53.9 kDa) calculated from amino acid sequences of rAgSRPN6.
This result indicates that rAgSRPN6 exists predominantly as a
monomer in solution and is not prone to form dimers or polymers
as previously reported for mutant forms of a1 antitrypsin [55] or
neuroserpin [56].
Native and rAgSRPN6 have a calculated pI of 9.6, which is
substantially more basic compared to most Anopheles serpins with
calculated pIs between 5 and 6. To test whether pH influences the
conformation of the protein we determined the far ultraviolet (UV)
circular dichroism spectra of recombinant SRPN6 at different pH.
The canonical native serpin fold is composed of a mixture of a-
helices, b-sheets, b-turns, and loops, presented as a minimum peak
at 222 nm preceded by a shoulder at 208 nm in the far-UV CD
spectra [57–59]. The far UV CD spectrum of SRPN6 is highly
similar to that of reported serpins (Fig. 3B). All spectra
demonstrated broad negative bands in the wavelength range of
208–222 nm, with [h]<29900 deg. cm2. dmol21 for SRPN6 at
pH 8.0 and 11.0, and [h]<210500 deg. cm2. dmol21 for SRPN6
at pH 5.0. The general shape of the CD spectra at pH 5.0, 8.0 and
11.0 was approximately indistinguishable, suggesting that recom-
binant SRPN6 kept the same high degree of secondary structure
under either acid or basic conditions.
The native conformation of serpins, which generally represents
the active conformation of the protein, is the least stable
conformation. This is reflected in an average midpoint unfolding
temperature (Tm) of the native form of about 58uC, while serpin
molecules in the latent conformation usually display melting
temperatures of 85–90uC ([60], and references within). The
thermal stability of recombinant SRPN6 was analyzed by
Differential scanning calorimetry (DSC). As shown in Fig. 3C,
rAgSRPN6 displayed a Tm of 56uC. The DSC thermogram was
distorted at temperatures higher than the Tm, most likely due to
aggregation of rAgSRPN6 at higher temperatures. No heat
capacity peak was observed during the second DSC scan,
suggesting that the SRPN6 structure was destroyed completely
when the temperature increased above 56–58uC and denaturation
was irreversible even when the temperature decreased below Tm.
Accordingly, rAgSRPN6 protein concentration in solution de-
creased around 55uC (Fig. 3D), due to protein aggregation and
precipitation. Taken together, the DSC analysis results are
consistent with rAgSRPN6 protein taking on a native conforma-
tion in solution, with little or no propensity for a latent
conformation.
Figure 1. Structure model of AgSRPN6. Ribbon structure (A) and
electrostatic surface representation (B) of the I-Tasser model with the
highest C-score (20.77). Highlighted in pink are the first 41 amino acids
of SRPN6, which constitute an N-terminal extension unique to
AgSRPN6. This extension is in close proximity to a 27 amino acid long
insertion located between helix D and strand 2A (yellow). This insertion
forms two short alpha helices and contains a stretch of acidic residues,
which form a negatively charged surface area, highlighted by a black
arrow. Bright red, sheet A; blue, sheet B; tan, sheet C; green, a-helices;
cyan, RCL. Blue surface, negative charges; red surface, positive charges.
doi:10.1371/journal.pone.0048689.g001
Characterization of Anopheles gambiae SRPN6
PLOS ONE | www.plosone.org 4 November 2012 | Volume 7 | Issue 11 | e48689
Inhibitory activity of recombinant rSRPN6
The functionality of purified rAgSRPN6 was assayed in
commercial proteinase inhibition tests, in which the enzymatic
activity of proteinases was monitored using chromogenic sub-
strates. The tested proteinases included mammalian digestive
enzymes (trypsin, chymotrypsin), mammalian tissue proteinases
with distinct functions (elastase, kallikrein), several serine protein-
ases from human blood (cathepsin G, plasmin, thrombin) and
subtilisin-like proteinases (proteinase K, subtilisin Carlsberg).
SRPN6 has the basic residue Arginine at the predicted P1 site,
suggesting it as a potential inhibitor of trypsin-like serine
proteinases, which prefer Arginine or Lysine at the N-terminal
residues of the target peptide bond. The results are summarized in
Table 1. As expected based on the substrate specificity of the
proteinase, rAgSRPN6 had no inhibitory activity against cathepsin
G, chymotrypsin, proteinase K, or elastase. Plasmin, subtilisin
Carlsberg, thrombin, trypsin, and kallikrein prefer an Arg, or Lys at
the P1 site, and therefore are potential inhibitory targets of
SRPN6. However, rAgSRPN6 did not inhibit Plasmin, subtilisin
Carlsberg, thrombin, and only weakly inhibited trypsin by ,13% at
a serpin/trypsin molar ratio of 10:1. rSRPN6 inhibited kallikrein
most efficiently among all tested commercial proteinases, with
44% and 75% inhibition at rAgSRPN6/kallikrein ratio of 1:1 and
Figure 2. Production of rAgSRPN6. (A) Schematic representation of rAgSRPN6. Letters above the boxes represent the amino acid residues and
the numbers underneath indicate their positions in wild type AgSRPN6. Predicted P1-P19 cleavage sites are indicated by arrows. (B) SDS-PAGE analysis
of purified rAgSRPN6. Fraction #16, #18, #20, and #22 from SP-sepharose cation exchange chromatography (1 mg/sample, Lane 1–4 respectively)
were separated by 10% SDS-PAGE followed by commassie blue staining. Lane 5: 1 mg of rAgSRPN6 (faction #22) was incubated with 36109 E. coli
XL1-blue cells at room temperature for 15 min and subjected to SDS-PAGE. Lane 6: 36109 E. coli XL1-blue cells.
doi:10.1371/journal.pone.0048689.g002
Figure 3. Biophysical and structural parameters of rAgSRPN6. (A) Sedimentation velocity analysis of rAgSRPN6. Dialyzed rAgSRPN6 (1 mg/
ml) was evaluated by analytical ultracentrifugation. Data were analyzed using DCDT+ software version 1.16 [48]. (B) Far-UV CD spectra of rAgSRPN6.
The protein was dissolved in 20 mM Tris-HCl buffer containing 250 mM NaCl with pH of 8.0 (—) or 5.0 (—) or 11.0 (– -). [h] represents mean residue
elliplicity defined in ‘‘Material and methods’’. (C) Calorimetric scans of rAgSRPN6. Samples were prepared by dialysis against 20 mM Tris and 250 mM
NaCl, pH 8.0 and analyzed by DSC. Traces were baseline-corrected by subtraction of a scan of buffer. (D) SDS-PAGE analysis of purified rAgSRPN6
heated at different temperatures. One mg of purified rAgSRPN6 was heated at 30, 35, 40, 45, 50, 55, 60, and 65uC for 5 min, respectively, and
centrifuged at 13,000 rpm for 5 min. The supernatants were separated by 10% SDS-PAGE followed by commassie blue staining (Lane 1–8
respectively). Lane 9: Supernatant from 1 mg of rAgSRPN6 analyzed after DSC scan.
doi:10.1371/journal.pone.0048689.g003
Characterization of Anopheles gambiae SRPN6
PLOS ONE | www.plosone.org 5 November 2012 | Volume 7 | Issue 11 | e48689
10:1, respectively. Kallikrein activity decreased linearly as
rAgSRPN6 concentration increased (Fig. 4). Therefore,
rAgSRPN6 (and most likely the native protein) is a functional
serine proteinase inhibitor. Its inhibitory specificity is distinct from
that of aFXa [61] and SRPN2 [24], the only other mosquito
serpins that have been characterized biochemically.
Recombinant SRPN6 forms SDS-stable complexes with
insect serine proteinases
Knockdown of AgSRPN6 increases the number of melanized
ookinetes in the refractory L3–5 strain as well as in CTL4-depleted
mosquitoes [29]. One potential explanation for these observations
is that AgSRPN6 under normal physiological conditions suppress-
es melanization of parasites, by inhibiting one or more PAPs and
thus preventing activation of proPO and melanization. To test this
hypothesis, we made use of the M. sexta melanization cascade,
which is established in vitro and ex vivo. A characteristic feature of a
serpin-proteinase reaction is the formation of a high molecular
weight, SDS-stable complex [62]. We made use of M. sexta serine
proteinase PAP1, PAP3, and HP6 to investigate whether
rAgSRPN6 can form such complex in vitro. M. sexta PAP1
antibodies recognized a 34 kDa band corresponding to the
catalytic domain of PAP1 but not rAgSRPN6 (Fig. 5A, right
panel). After the two proteins were incubated together, the 34 kDa
catalytic domain became fainter and a new immunoreactive band
migrated to the ,80 kDa position anticipated for a complex of
rAgSRPN6 and PAP1 catalytic domain. This ,80 kDa band was
also detected by AgSRPN6 antibodies produced against the last
201 amino acid residues of AgSRPN6 (Fig. 5A, left panel),
indicating that it was composed of these two proteins. Mass-spec
analysis confirmed the presence of rAgSRPN6 and PAP1 in the
,80 kDa band (data not shown). Surprisingly, the previously
published antiserum raised against soluble full-length rAgSRPN6
[29] did not recognize this complex (Fig. S2).
Similar results were obtained for the interaction between
rAgSRPN6 and PAP3 (Fig. 5B). The interaction of rAgSRPN6
and PAP3 resulted in the formation of an ,80 kDa complex
under reducing conditions, which was absent from the control
lanes with only PAP3 or SRPN6 alone. This complex was
recognized by both rAgSRPN6 antibodies and M. sexta PAP3
antibodies (Fig. 3B) indicating that SRPN6 can also form a
covalent complex with PAP3.
Consistent with previous report [47], anti-HP6 antiserum
recognized the 39 kDa proHP6 zymogen and a 33 kDa truncated
HP6 in the absence of factor Xa, and after activation with factor
Xa, a 29 kDa band corresponding to the catalytic domain of
HP6Xawas detected by the HP6 antiserum (Fig. 5C, right
panel).When rAgSRPN6 was mixed with active HP6Xa, a new
immunoreactive band at,72 kDa position (the expected size for a
SRPN6:HP6Xa complex) was observed. This band was also
recognized by AgSRPN6 antiserum (Fig. 5C, left panel). The
incubation of truncated AgSRPN6 (SRPN6DN) and active HP6Xa
also resulted in the appearance of 72 kDa band recognized by
both antibodies (Fig. 3C), indicating truncated SRPN6 retains the
ability to form SDS-stable inhibitory complexes with proteinases.
The high Mr, covalent complex formation between rAgSRPN6
and PAP1, PAP3, and HP6 supports the hypothesis that
AgSRPN6 can regulate melanization as these three proteinases
are critical components of the proPO activation pathway in M.
sexta [18,47,49]. To further test this hypothesis, we investigated
AgSRPN6’s effect on proPO activation ex vivo. Naı¨ve hemolymph
from day 2 fifth instar M. sexta larvae has low basal PO activity,
and exposure of M. luteus significantly increased the PO activity of
hemolymph (Fig. 5D and [63]). Pre-incubation of hemolymph
with rAgSRPN6 significantly decreased PO activity (Fig. 3D).
Therefore, rAgSRPN6 had inhibitory effect on the proPO
activation in M. sexta hemolymph, most likely by inhibiting
PAP1, PAP3 and HP6 in the hemolymph. These findings are
consistent with our working hypothesis that one function of
AgSRPN6 is regulating melanization in vivo.
Recently, the first PAP from An. gambiae was identified and
characterized biochemically. AgCLIPB9 is part of a regulatory
unit that controls melanization in adult females, by functioning as
a PAP. However, active recombinant CLIPB9Xa did not form
inhibitory complexes with rAgSRPN6 (Fig. S3), and its amidase
activity was unaltered in the presence of rSRPN6. However,
additional PAPs are likely to be present in the hemolymph of
mosquitoes, which may be inhibited by SRPN6. Antibodies
against the last 201 amino acid residues of AgSRPN6 that were
Figure 4. Stoichiometry of inhibition of kallikrein by
rAgSRPN6. Recombinant AgSRPN6 was incubated with porcine
kallikrein at different molar ratios for 10 min at room temperature.
The residual amidase activity was measured using FPRpNa as substrate.
doi:10.1371/journal.pone.0048689.g004
Table 1. Proteinase inhibition assays with rAgSRPN6.
Predicted
cleaved site
rSRPN6:
Proteinase Cath G CHY ELA KAL PLAS Pro K Sub C THRMB TRYP
LVDR
I IGSQ
1:1 – – – 44.061.7 – – – – –
10:1 – – – 74.961.0 – – – – 13.065.1
Human cathepsin G (Cath G), bovine chymotrypsin (CHY), porcine elastase (ELA), porcine kallikrein (KAL), Human plasmin (PLAS), Fungus protease K (ProK), Bacilus
licheniformis Subtilisin Carlsberg (SubC), human thrombin (THRMB), and bovine trypsin (TRYP) were incubated with purified rAgSRPN6 and assayed for residual enzyme
activity. ‘‘–’’, inhibition ,10%. Values represent mean percent inhibition 6 S.D. (n = 3).
doi:10.1371/journal.pone.0048689.t001
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created for this project do recognize the native state of the serpin
and also bind to serpin-proteinase complexes formed with
heterologous proteinases in vitro. However, no SRPN6-proteinase
complexes were identified in hemolymph, supernatants of the
hemocyte-like 4a3B An. gambiae cell line [64], and P. berghei-infected
epithelia (data not shown), suggesting that the endogenous target(s)
of AgSRPN6 are either absent or present in undetectable
concentrations under physiological conditions.
Conclusions
Structural modeling of AgSRPN6 suggested that this serpin can
take on the metastable classical serpin fold, which is supported by
the biophysical data presented in this study. The biochemical
characterization confirmed that rAgSRPN6 is indeed an inhibitor
of trypsin-like serine proteinases. Additionally, this study provides
the first biochemical evidence that AgSRPN6 controls the
melanization response by inhibiting proteinases of the pro-
phenoloxidase activation pathway. It is noteworthy that we found
Figure 5. SDS-stable complex formation between rAgSRPN6 and M. sexta PAP1, PAP3, and HP6. Purified rAgSRPN6 was incubated with
M. sexta PAP1 (A) or PAP3 (B) for 10 min at room temperature. The mixtures were subjected to SDS-PAGE under reducing conditions, and the
complex was detected by immunoblotting using antisera against either AgSRPN6 (left panel) or MsPAP (right panel). (C) ProHP6Xa was activated by
factor Xa and then incubated for 10 min at room temperature with rAgSRPN6 at a molar ratio of 10:1 (rAgSRPN6:proHP6Xa). In control reactions,
proHP6Xa or factor Xa were omitted. The samples were subjected to SDS-PAGE and immunoblot analysis using antiserum against AgSRPN6 (left
panel) or MsHP6 (right panel). Size and positions of molecular mass standards are indicated to the left of the blots. Asterisks, rAgSRPN6-proteinase
complex; triangles, non-complexed rAgSRPN6; diamond; SRPN6DN; circles, proHP6Xa zymogen; squares, catalytic domain of serine proteinase. (D)
Inhibition of ProPO activation in M. sexta hemolymph by rAgSRPN6. 1 ml of cell-free hemolymph was incubated with 200 ng of rAgSRPN6 or
rAgSRPN7. 10 min later, ProPO activation was triggered by the addition of M. luteus to a final concentration of 3 mg/ml. PO activity (mean6S.D., n = 3)
was measured after 10 min in a spectrophotometer as described in ‘‘Material and Methods’’. Letters above columns indicate significance levels of
P,0.0001 (One way ANOVA, Newman-Keuls multiple comparison test).
doi:10.1371/journal.pone.0048689.g005
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differences between the abilities of different antisera to recognize
higher molecular weight complexes between rAgSRPN6 and
target proteinases. The new antiserum raised against a C-terminal
polypeptide of AgSRPN6 is a key step towards future identification
of the cognate proteinase targets and will allow the identification of
novel components of the proPO and or complement pathway in
mosquitoes.
Supporting Information
Figure S1 SDS-PAGE of recombinant SRPN6Ag. The last
201 amino acid residues of SRPN6 (SRPN6Ag) were expressed in
E. coli and purified under denaturing conditions. 10 ml of elution
fraction #1-#5 (Lane 1–5, respectively) were separated by 10%
SDS-PAGE followed by Coomassie Blue staining.
(TIF)
Figure S2 Detection of SDS-stable complex formation
between An. gambiae SRPN6 and M. sexta PAP1. Purified
recombinant SRPN6 (200 ng) was incubated with M. sexta PAP1
(15 ng) at room temperature for 10 min. The mixtures were
subjected to SDS-PAGE and immunoblot analysis using previ-
ously published antisera against either full-length rSRPN6 (left
panel) or MsPAP1 (right panel). The band with apparent molecular
weight of 80 kDa (the expected size for a SRPN6:PAP1 complex)
was recognized by MsPAP1 antibodies (right panel), but not by
antibodies against recombinant full length SRPN6 (left panel).
However, this band was detected by the antibodies against
SRPN6Ag (Fig. 5A–5C). Asterisks, SRPN6-PAP1 complex;
triangles, non-complexed rSRPN6; squares, active PAP1.
(TIF)
Figure S3 No covalent complex formed between
rSRPN6 and serine proteinase CLIPB8 and CLIPB9.
Recombinant SRPN2 was incubated with Factor Xa-activated
CLIPB9Xa. Western blot analysis was performed using rabbit
anti-SRPN6 antibodies against recombinant SRPN6Ag. No
complex band except recombinant rSRPN6 was detected. A
smaller band was detected after incubation with FactorXa,
suggesting that rSRPN6 constitutes a substrate for this proteinase.
Triangles, non-complexed full-length rSRPN6; diamond, cleaved
rSRPN6.
(TIF)
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